- Home
- Publications
- Publication Search
- Publication Details
Title
Activation of PPARδ: from computer modelling to biological effects
Authors
Keywords
-
Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume 172, Issue 3, Pages 754-770
Publisher
Wiley
Online
2014-09-26
DOI
10.1111/bph.12950
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nuclear receptors in neurodegenerative diseases
- (2014) Rebecca Skerrett et al. NEUROBIOLOGY OF DISEASE
- Role of Peroxisome Proliferator-Activated Receptor (PPAR)δ in Embryonic Stem Cell Proliferation
- (2014) Min Young Lee et al. International Journal of Stem Cells
- Peroxisome proliferator-activated receptor delta and cardiovascular disease
- (2013) Ewa Ehrenborg et al. ATHEROSCLEROSIS
- Tau hyperphosphorylation and increased BACE1 and RAGE levels in the cortex of PPARβ/δ-null mice
- (2013) Emma Barroso et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- The Concise Guide to PHARMACOLOGY 2013/14: Nuclear Hormone Receptors
- (2013) Stephen P.H. Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- Fatty acids and early detection of pathogens
- (2013) Justin W Walley et al. CURRENT OPINION IN PLANT BIOLOGY
- Molecular determinants for nuclear receptors selectivity: Chemometric analysis, dockings and site-directed mutagenesis of dual peroxisome proliferator-activated receptors α/γ agonists
- (2013) Antonio Carrieri et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Signaling properties of 4-hydroxyalkenals formed by lipid peroxidation in diabetes
- (2013) Guy Cohen et al. FREE RADICAL BIOLOGY AND MEDICINE
- Looking at nuclear receptors from a new angle
- (2013) Christine Helsen et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- A peroxisome proliferator-activated receptor-δ agonist provides neuroprotection in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson’s disease
- (2013) H.L. Martin et al. NEUROSCIENCE
- The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands
- (2013) Adam J. Pawson et al. NUCLEIC ACIDS RESEARCH
- Lipidomics of polyunsaturated-fatty-acid-derived oxygenated metabolites
- (2012) Karen A. Massey et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- The hinge region in androgen receptor control
- (2012) Liesbeth Clinckemalie et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Structural Insights into Human Peroxisome Proliferator Activated Receptor Delta (PPAR-Delta) Selective Ligand Binding
- (2012) Fernanda A. H. Batista et al. PLoS One
- PPARs at the crossroads of lipid signaling and inflammation
- (2012) Walter Wahli et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- The Role of PPARβ/δ in the Management of Metabolic Syndrome and its Associated Cardiovascular Complications
- (2012) Elisa Benetti et al. Endocrine Metabolic & Immune Disorders-Drug Targets
- Phenoxyacetic acids as PPARδ partial agonists: Synthesis, optimization, and in vivo efficacy
- (2011) Karen A. Evans et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Sulfonylthiadiazoles with an Unusual Binding Mode as Partial Dual Peroxisome Proliferator-Activated Receptor (PPAR) γ/δ Agonists with High Potency and in vivo Efficacy
- (2011) Stefanie Keil et al. ChemMedChem
- Role of Lipid Peroxidation and PPAR-δ in Amplifying Glucose-Stimulated Insulin Secretion
- (2011) Guy Cohen et al. DIABETES
- Lipid Mediators in Life Science
- (2011) Makoto MURAKAMI EXPERIMENTAL ANIMALS
- Structural Basis for Iloprost as a Dual Peroxisome Proliferator-activated Receptor α/δ Agonist
- (2011) Lihua Jin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Lipid peroxidation of poly-unsaturated fatty acids in normal and obese adipose tissues
- (2011) G. Cohen et al. ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
- Discovery of isoindoline and tetrahydroisoquinoline derivatives as potent, selective PPARδ agonists
- (2010) Christopher A. Luckhurst et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The Natural Protective Mechanism Against Hyperglycemia in Vascular Endothelial Cells: Roles of the Lipid Peroxidation Product 4-Hydroxydodecadienal and Peroxisome Proliferator-Activated Receptor
- (2010) Y. Riahi et al. DIABETES
- Peroxisome Proliferator-Activated Receptor Regulation of miR-15a in Ischemia-Induced Cerebral Vascular Endothelial Injury
- (2010) K. J. Yin et al. JOURNAL OF NEUROSCIENCE
- Evidence for the Role of Peroxisome Proliferator-Activated Receptor- / in the Development of Spinal Cord Injury
- (2010) I. Paterniti et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Peroxisome Proliferator-Activated Receptor (PPAR)β /δ: A New Potential Therapeutic Target for the Treatment of Metabolic Syndrome
- (2010) Teresa Coll et al. Current Molecular Pharmacology
- Adaptability and selectivity of human peroxisome proliferator-activated receptor (PPAR) pan agonists revealed from crystal structures
- (2009) Takuji Oyama et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Identification of a PPARδ agonist with partial agonistic activity on PPARγ
- (2009) Richard V. Connors et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A PPARdelta Agonist Reduces Amyloid Burden and Brain Inflammation in a Transgenic Mouse Model of Alzheimers Disease
- (2009) Sergey Kalinin et al. Current Alzheimer Research
- Comparison of PPARδ and PPARγ in inhibiting the pro-inflammatory effects of C-reactive protein in endothelial cells
- (2009) Yao-Jen Liang et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Activation of PPARβ/δ inhibits leukocyte recruitment, cell adhesion molecule expression, and chemokine release
- (2009) Laura Piqueras et al. JOURNAL OF LEUKOCYTE BIOLOGY
- 15-Hydroxyeicosatetraenoic Acid Is a Preferential Peroxisome Proliferator-Activated Receptor / Agonist
- (2009) S. Naruhn et al. MOLECULAR PHARMACOLOGY
- Retinoic acid activation of peroxisome proliferation-activated receptor δ represses obesity and insulin resistance
- (2009) George Wolf NUTRITION REVIEWS
- Regulation of Skeletal Muscle Physiology and Metabolism by Peroxisome Proliferator-Activated Receptor
- (2009) E. Ehrenborg et al. PHARMACOLOGICAL REVIEWS
- Peroxisome proliferator-activated receptor beta/delta (PPARβ/δ) acts as regulator of metabolism linked to multiple cellular functions
- (2009) Kay-Dietrich Wagner et al. PHARMACOLOGY & THERAPEUTICS
- Molecular mechanism of allosteric communication in the human PPARα-RXRα heterodimer
- (2009) Tuomas Venäläinen et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- Structure and physiological functions of the human peroxisome proliferator-activated receptor γ
- (2008) Andrzej Zieleniak et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Role of PPAR-beta in hydrogen peroxide-induced apoptosis in human umbilical vein endothelial cells
- (2008) Bimei Jiang et al. ATHEROSCLEROSIS
- Peroxisome Proliferator-Activated Receptor δ-Agonist, GW501516, Ameliorates Insulin Resistance, Improves Dyslipidaemia in Monosodium l-Glutamate Metabolic Syndrome Mice
- (2008) Wei Chen et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Discovery of a novel class of PPARδ partial agonists
- (2008) Barry G. Shearer et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Structure of the intact PPAR-γ–RXR-α nuclear receptor complex on DNA
- (2008) Vikas Chandra et al. NATURE
- PPAR regulates multiple proinflammatory pathways to suppress atherosclerosis
- (2008) G. D. Barish et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agent
- (2008) D. R. Artis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Suppression of Pro-inflammatory Adhesion Molecules by PPAR-δ in Human Vascular Endothelial Cells
- (2007) Yanbo Fan et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Effect of heterodimer partner RXRα on PPARγ activation function-2 helix in solution
- (2007) Jianyun Lu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More